Literature DB >> 24503795

Temperament and character and quality of life in lung cancer patients.

Suzana Kukulj, Branka Aukst Margetic, Miro Jakovljevic, Miroslav Samarzija.   

Abstract

AIM: The aim of this study was to test whether personality variables are independently associated with health-related quality of life (HRQOL) in lung cancer patients.
METHODS: In a cross-sectional study, 86 non-small cell lung cancer patients and 73 healthy subjects matched for gender and age were assessed with the Temperament and Character Inventory. In the patient group QOL was assessed with EORTC QLQ-C30. We used multiple linear regressions to determine whether personality dimensions predict HRQOL. Data on tumor stage, patient age, education and marital status were also collected.
RESULTS: Lung cancer patients differed from healthy controls in the temperament dimension of persistence and the character dimension of self-transcendence. The temperament dimension of harm avoidance and the character dimension of cooperativeness were significant predictors of QOL functional scales and global health status.
CONCLUSIONS: In lung cancer patients, the personality dimensions of harm avoidance and cooperativeness showed associations with most QOL dimensions. Personality factors are relevant for patients' QOL perception and should be included in cancer patients' QOL assessment.

Entities:  

Mesh:

Year:  2013        PMID: 24503795     DOI: 10.1177/030089161309900611

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  2 in total

1.  Effect of refractive error on temperament and character properties.

Authors:  Emine Kalkan Akcay; Fatih Canan; Huseyin Simavli; Derya Dal; Hacer Yalniz; Nagihan Ugurlu; Omer Gecici; Nurullah Cagil
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

2.  Personality (at Intrapsychic and Interpersonal Level) Associated With Quality of Life in Patients With Cancer (Lung and Colon).

Authors:  Maria Velia Giulietti; Anna Vespa; Marica Ottaviani; Rossana Berardi; Giancarlo Balercia; Giorgio Arnaldi; Pisana Gattafoni; Paolo Fabbietti; Mirko Di Rosa; Roberta Spatuzzi
Journal:  Cancer Control       Date:  2019 Jan-Dec       Impact factor: 3.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.